HKXCF (HKXCF) Stock Price & Analysis
HKXCF (HKXCF) rose 7.25% to USD 52.8 as of July 25, 2026 at 05:36 UTC, according to Nexqual real-time market data.
HKXCF last closed at USD 49.23; the session ranged USD 50.75–50.75 on volume of 300 shares. Market capitalization is $68.91B, with a 52-week range of USD 44.59–60.59 (PNK). Source: Nexqual, July 25, 2026 at 05:36 UTC.
Key Statistics (as of July 25, 2026 at 05:36 UTC)
| Price | USD 52.8 |
|---|---|
| Change | ▲ 7.25% (up) |
| Previous Close | USD 49.23 |
| Open | USD 50.75 |
| Day Range | USD 50.75 – 50.75 |
| 52-Week Range | USD 44.59 – 60.59 |
| Volume | 300 shares |
| Market Cap | $68.91B |
| Exchange | PNK |
Technical Analysis (HKXCF)
Nexqual's technical model rates HKXCF "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 05:36 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 61.5 (neutral) |
| vs SMA50 | Above (USD 49.53) |
| MACD | 0.41 (positive) |
Analyst Ratings (HKXCF)
Wall Street analysts rate HKXCF "None", per Nexqual as of July 25, 2026 at 05:36 UTC.
| Consensus Rating | None |
|---|
Earnings (HKXCF)
| Next Earnings Date | 2026-08-19 |
|---|---|
| Revenue Estimate | $7.94B |
Source: Nexqual, July 25, 2026 at 05:36 UTC.
Financials & Fundamentals (HKXCF)
| Total Revenue | $30.15B |
|---|---|
| Revenue Growth (YoY) | +19.00% |
| Gross Margin | +96.53% |
| Operating Margin | +77.20% |
| Profit Margin | +62.57% |
| ROE | +35.00% |
| Debt / Equity | 2.19 |
| Current Ratio | 1.05 |
| Total Cash | $308.61B |
| Total Debt | $1.22B |
Source: Nexqual, July 25, 2026 at 05:36 UTC.
Financial Health Score (HKXCF)
Nexqual rates HKXCF's overall financial health "Strong" across five dimensions, as of July 25, 2026 at 05:36 UTC.
| Growth | Strong — Revenue +30% YoY (annual) |
|---|---|
| Profitability | Strong — Operating margin 77% |
| Balance Sheet | Strong — $308.6B cash vs $1.22B debt, net cash position |
| Cash Flow | Mixed — No data |
| Efficiency | Strong — ROE 35%, ROA 3.0% |
Ownership (HKXCF)
| Insider Ownership | +6.20% |
|---|---|
| Institutional Ownership | +33.11% |
| Shares Outstanding | 1.26B |
| Float | 1.19B |
Source: Nexqual, July 25, 2026 at 05:36 UTC.
Leadership (HKXCF)
HKXCF is led by Yiting Chan (age 55), CEO & Executive Director, per Nexqual as of July 25, 2026 at 05:36 UTC.
| CEO & Executive Director | Yiting Chan (age 55) |
|---|---|
| Group Chief Financial Officer | Leung-Wah Hui C.F.A. (age 62) |
| Chief Operating Officer | Bik Yun Lau (age 53) |
| MD & Group CTO | John Hsu |
Major Backers & Investors (HKXCF)
Notable institutional backers of HKXCF include NEW PERSPECTIVE FUND, Fidelity, J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci, according to Nexqual as of July 25, 2026 at 05:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| NEW PERSPECTIVE FUND | 0.54% |
| Fidelity | 0.36% |
| J.P. Morgan Exch-Trd Fd. TRT-JPMorgan BetaBuilders Developed Asia Paci | 0.27% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.51% |
| BlackRock | 1.39% |
Source: Nexqual, July 25, 2026 at 05:36 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HKXCY | Hong Kong Exchange & Clearing L | USD 50.83 | ▼ 0.78% |
| LDNXF | London Stock Exchange Group plc | USD 119.54 | ▲ 4.17% |
| DBOEF | Deutsche Boerse AG | USD 289.83 | ▲ 1.11% |
| SHECF | Shin-Etsu Chemical Co., Ltd. | USD 36.85 | ▼ 11.93% |
| KDDIF | KDDI Corp. | USD 18 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:36 UTC. This page is informational and not investment advice.